Jupiter Life Line Hospitals vs Trane Technologies: Fair Value & Quality
Both stocks run through our valuation models. Here is how Jupiter Life Line Hospitals (JLHL) and Trane Technologies (TT) compare, as of Aug 18, 2026.
As of Aug 18, 2026, Fair Value Calculator sees Trane Technologies as the less overvalued of the two: Jupiter Life Line Hospitals trades at ₹315 versus a fair value of ₹123 (-61%), while Trane Technologies trades at $475 versus $209 (-56%).
Jupiter Life Line Hospitals
JLHL.NSE · INR · Health Care
-61%
upside to fair value
overvalued
Price₹315
Fair Value₹123
Quality46/100
Trane Technologies
TT · USD · Industrials
-56%
upside to fair value
overvalued
Price$475
Fair Value$209
Quality74/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Jupiter Life Line HospitalsTrane Technologies
Valuation
49.1×P/E (TTM)36.7×
6.35×P/S (TTM)4.81×
6.17×P/B12.08×
30.5×EV/EBITDA25.1×
—PEG2.00×
0.1%Dividend yield0.8%
₹1.00Dividend per share$3.87
Profitability
13%Net margin13%
17%Operating margin16%
13%Return on equity37%
7%Return on assets11%
Growth
4%Revenue growth (YoY)6%
18.9%Avg. growth/yr (3Y)10.1%
25.3%Avg. growth/yr (5Y)11.4%
Balance & size
0.32×Debt / equity0.46×
$1,000MMarket cap$104B
expensiveGrowth qualityhealthy
Trane Technologies leads: 5 to 8 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Jupiter Life Line Hospitalsof which business quality 48 · market factors 48Trane Technologiesof which business quality 71 · market factors 54
ProfitabilityMargins and returns on capital today
55
76
Quality GrowthAre margins and returns improving?
33
52
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
0
70
Low VolatilityCalm price path (market factor)
50
59
MomentumPrice trend over the last 3–12 months (market factor)
63
46
52W MomentumDistance to the 52-week high (market factor)
22
64
Net IssuanceBuybacks instead of dilution
81
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Jupiter Life Line Hospitals
Earnings-Based₹132
Dividend Discount₹3.82
Multiples₹119
Asset-Based₹34.24
Economic Profit₹60.15
Growth Earnings₹183
16 of 16 models see the stock below the current price.
Trane Technologies
DCF Models$213
Earnings-Based$112
Dividend Discount$63.35
Multiples$219
Asset-Based$26.07
Growth DCF$189
Economic Profit$153
Growth Earnings$235
26 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Jupiter Life Line Hospitals
Bear ₹87.89Fair Value ₹123Bull ₹158
₹315 = current price (white tick)
Trane Technologies
Bear $134Fair Value $209Bull $306
$475 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Jupiter Life Line Hospitals · Health Care
Quality score46 · below median
Fair value upside-61% · below median
Trane Technologies · Industrials
Quality score74 · Top 25%
Fair value upside-56% · below median
Bottom line
As of Aug 18, 2026, Fair Value Calculator sees Trane Technologies as the less overvalued of the two: Jupiter Life Line Hospitals trades at ₹315 versus a fair value of ₹123 (-61%), while Trane Technologies trades at $475 versus $209 (-56%).
Trane Technologies has the higher quality score (74/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
